Night eating syndrome: implications for severe obesity.

Department of Obesity & Endocrinology, University of Liverpool, Liverpool, UK.
Nutrition & Diabetes (Impact Factor: 1.52). 09/2012; 2:e44. DOI: 10.1038/nutd.2012.16
Source: PubMed

ABSTRACT Night eating syndrome (NES) was first identified in 1955 by Stunkard, a psychiatrist specialising in eating disorders (ED). Over the last 20 years considerable progress has been made in defining NES as a significant clinical entity in its own right and it has now been accepted for inclusion in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) due for publication in 2013. NES is considered a dysfunction of circadian rhythm with a disassociation between eating and sleeping. Core criteria include a daily pattern of eating with a significantly increased intake in the evening and/or night time, as manifested by one or both of the following: at least 25% of food intake is consumed after the evening meal or at least two episodes of nocturnal eating per week. An important recent addition to core criteria includes the presence of significant distress and/or impairment in functioning. Stunkard's team recommend further investigation on the pathogenesis of NES, in particular its relationship with traumatic life events, psychiatric comorbidity, the age of onset of NES and course of NES over time. The relationship between NES and other ED also requires further clarification as night-eaters exhibit some features of other ED; previous guidance to separate NES from other ED may have hindered earlier characterisation of NES. Evidence from European and American studies suggests NES features strongly in populations with severe obesity. The complex interplay between depression, impaired sleep and obesity-related comorbidity in severely obese individuals makes understanding NES in this context even more difficult. This review examines evidence to date on the characterisation of NES and concludes by examining the applicability of current NES criteria to individuals with severe obesity.

1 Bookmark
  • Source
    Frontiers in Public Health 06/2014; 2:59.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We aimed to investigate the prevalence of night eating syndrome (NES) in a large cohort of patients with restless legs syndrome (RLS). Our cross-sectional study included 120 patients examined at the University of Bologna Centre for Sleep Disorders, Bologna, Italy, and met all four International RLS criteria for the diagnosis of RLS. Each patient underwent a semistructured telephone interview investigating demographic data and general health status, RLS features and severity, presence of excessive daytime sleepiness, and presence of NES. The sample included 37 men and 83 women with a mean age of 63.8±11.5years. There were 31% of patients who reported episodes of nocturnal eating (NE); among them, 17% fulfilled the new diagnostic criteria for NES. Comparing RLS patients with and without NE, there were no differences in RLS features. However, RLS patients with NE were older (67.2±11.6 vs 62.4±11; P=.038), were in a higher body mass index (BMI) range (27.7±3.8 vs 26.1±4.1kg/m(2); P=.023), were taking more drugs for concomitant diseases (89% vs 72%; P=.031), were more likely to report insomnia (40% vs 23%; P=.041), and were using more hypnotic agents (37.8% vs 19.3%; P=.050) and dopaminergic drugs (65% vs 46%; P=.041). When comparing those RLS patients with NES diagnostic criteria and those without NES, no differences emerged in demographic, clinical, and RLS features; however, NES patients were in a higher BMI range (28.3±4.1 vs 26.2±3.9kg/m(2), P=.037), were more frequently smokers (43% vs 17%; P=.027), and were more frequently using hypnotic agents (30% vs 24%; P=.025). Lastly, no differences were found when comparing patients with a NES diagnosis and those with NE not fitting the diagnostic criteria for NES, except for a higher use of benzodiazepine drugs (BDZ) in this latter subgroup (29% vs zero; P=.014). A nocturnal compulsion to eat seems to be an intrinsic part of the clinical spectrum of RLS manifestations and an odd risk factor for increases in BMI in RLS patients. However, it is still not clear if NE in RLS would fit in one of the two known categorized syndromes of NE (i.e., sleep-related eating disorder [SRED] or NES) or if it represents a different strictly RLS-related eating behavior.
    Sleep Medicine 12/2013; · 3.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives, design: The aim of this case control study was to investigate possible associations of the variable number tandem-repeat (VNTR) polymorphism in the PER3 gene with obesity-related anthropometric traits, sleep and nutritional behaviour. Setting: A total of 329 volunteers of the Czech Caucasian origin were enrolled in the study. The allele-specific PCR-based method was used to determine the VNTR PER3 genotypes, dietary composition and time patterns were evaluated using seven day native food records and seven day sleep records. Results: No differences were observed in allele frequencies between the obese and the non-obese individuals. The PER3 VNTR polymorphism was associated with the total daily energy derived from carbohydrates (p p Conclusions: We have demonstrated the relationship between the PER3 VNTR polymorphism and behavioural patterns of the food intake in the Central-European population.
    Biological Rhythm Research 09/2014; 45(5). · 1.22 Impact Factor

Full-text (2 Sources)

Available from
Jun 1, 2014